Institutional investors hold a majority ownership of TEVA through the 58.38% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2017, these large investors purchased a net $11.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 648.6 Thousand shares of Teva Pharmaceutical
APG ASSET MANAGEMENT NV Bought 145.6 Thousand shares of Teva Pharmaceutical
CREATIVE PLANNING, INC. Bought 138.9 Thousand shares of Teva Pharmaceutical